Bio-Rad Laboratories BIO
NYSE BIO
$376.41 +12.15 (+3.34%)
As of: Aug 20, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Return on Capital Employed Growth (3y) (2013 - 2026)

Bio-Rad Laboratories (BIO) Return on Capital Employed Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (3y) (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -236.00
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 281.00
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 145.00
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 446.00
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -433.00
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 1,627.00
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -62.00
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 370.00
10 Bio-Rad Laboratories 10.08 Bn 8.46 Bn 345.80 Mn -239.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -239.00
Mar 31, 2026 -575.00
Dec 31, 2025 -835.00
Sep 30, 2025 110.00
Jun 30, 2025 -7,819.00
Mar 31, 2025 -260.00
Dec 31, 2024 84.00
Mar 31, 2024 121,416.00
Dec 31, 2023 -172.00
Sep 30, 2023 25.00
Jun 30, 2023 11.00
Mar 31, 2023 307.00
Dec 31, 2022 540.00
Sep 30, 2022 489.00
Jun 30, 2022 535.00
Mar 31, 2022 978.00
Dec 31, 2021 713.00
Sep 30, 2021 58.00
Jun 30, 2021 80.00
Mar 31, 2021 428.00